OM
TMCI icon

Opaleye Management’s Treace Medical Concepts TMCI Stock Holding History

Opaleye Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-702,245
Closed -$4.71M – 63
2025
Q3 		$4.71M Buy
+702,245
New +$4.59M 0.67% 27

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Opaleye Management's TMCI Position: Q4 2025 in Review

Opaleye Management sold out of Treace Medical Concepts (TMCI) in Q4 2025, closing a stake of 702,245 shares — an estimated $4.71M sold.

Opaleye Management first reported a position in TMCI in Q3 2025 and held it in 1 quarter. The position peaked at $4.71M in Q3 2025. 115 funds tracked by Wall St. Rank hold TMCI as of Q4 2025.

  • Opaleye Management reported no remaining Treace Medical Concepts position as of Q4 2025 after selling out during the quarter.
  • Opaleye Management sold 702,245 Treace Medical Concepts shares in Q4 2025, an estimated $4.71M.
  • Opaleye Management first reported a position in Treace Medical Concepts in Q3 2025 and held it in 1 quarter.
  • Opaleye Management's Treace Medical Concepts position peaked at $4.71M in Q3 2025.
  • 115 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2025.

Based on Opaleye Management's 13F filing for Q4 2025, filed 17 Feb 2026.